NattokinaseBenefits, Dosage & Interactions

Nattokinase exerts its primary biological effects through its potent fibrinolytic activity. Fibrin is a protein that forms the matrix of blood clots. Nattokinase directly degrades fibrin and fibrinogen (the soluble precursor to fibrin) in a similar manner to plasmin, the body's natural clot-dissolving enzyme. Specifically, nattokinase can directly hydrolyze fibrin, leading to the dissolution of thrombi (blood clots). Beyond its direct action, nattokinase is also believed to enhance the body's endogenous fibrinolytic system. It can activate plasminogen activator inhibitor-1 (PAI-1), which is a physiological inhibitor of plasminogen activators. By lowering PAI-1 levels, nattokinase promotes the activity of tissue plasminogen activator (t-PA), which in turn converts plasminogen into plasmin. Plasmin then breaks down fibrin. This dual mechanism – direct fibrinolysis and indirect enhancement of the body's own thrombolytic pathways – contributes to its overall anticoagulant and profibrinolytic effects. Furthermore, nattokinase has been reported to degrade other proteins associated with cardiovascular health, including those involved in arterial plaque formation. Some research suggests it may also influence blood pressure by inhibiting angiotensin-converting enzyme (ACE), an enzyme involved in regulating blood pressure. Inhibiting ACE leads to the relaxation of blood vessels and a reduction in blood pressure, offering another potential pathway through which nattokinase may support cardiovascular health. These mechanisms collectively underscore its potential role in maintaining healthy blood circulation and supporting cardiovascular function, as noted by research cited by resources like Examine.com and NIH ODS.

Nattokinase has been studied for several potential health benefits, primarily related to cardiovascular health and blood circulation. * **Fibrinolytic Activity:** The most prominent benefit identified is its ability to break down fibrin. This action is thought to contribute to maintaining healthy blood flow and may reduce the risk of excessive blood clot formation. Studies reviewed by Cochrane suggest that compounds with fibrinolytic activity can be beneficial for circulatory health. * **Blood Pressure Regulation:** Some research indicates that nattokinase may contribute to the maintenance of healthy blood pressure levels. This effect is hypothesized to be partly mediated by its ability to inhibit angiotensin-converting enzyme (ACE), similar to prescription ACE inhibitor medications, leading to vasodilation. A review of human studies referenced by NIH ODS has explored this potential. * **Support for Healthy Blood Circulation:** By promoting the breakdown of clots and potentially influencing blood pressure, nattokinase is believed to support overall healthy blood circulation. This is paramount for various aspects of health, including oxygen and nutrient delivery throughout the body. Its role in reducing blood viscosity has also been investigated. * **Potential in Atherosclerosis:** While more research is needed, some preliminary investigations have explored nattokinase's potential influence on atherosclerosis, a condition characterized by plaque buildup in arteries. Its fibrinolytic action and influence on blood viscosity might indirectly contribute to arterial health, according to early findings discussed by resources like PubChem. These benefits are under ongoing scientific investigation, and nattokinase is often utilized as a dietary supplement to support general cardiovascular wellness.

Research into nattokinase primarily comes from in vitro (test tube) studies, animal models, and a growing number of human clinical trials. Its fibrinolytic activity, which is the cornerstone of its proposed benefits, is well-established in laboratory settings. In vitro studies have directly demonstrated nattokinase's ability to degrade fibrin and fibrinogen, confirming its enzymatic action (PubChem). Human clinical trials, though often small scale, have explored various aspects of nattokinase's efficacy: * **Blood Pressure:** Several randomized, double-blind, placebo-controlled trials have investigated nattokinase's effect on blood pressure. A study cited by NIH ODS, involving subjects with pre-hypertension or stage 1 hypertension, showed a modest but statistically significant reduction in both systolic and diastolic blood pressure after several weeks of supplementation. Other studies corroborate these findings, suggesting a potential role in blood pressure management, particularly for those with elevated levels. * **Blood Clotting Factors:** Human studies have also shown that nattokinase can influence markers related to blood clotting and fibrinolysis. This includes reductions in fibrinogen levels, factor VII activity, and PAI-1 levels, indicating an enhancement of endogenous fibrinolytic activity. These observations align with the proposed mechanism of action, as detailed by comprehensive reviews on DrugBank. * **Atherosclerosis and Lipid Profiles:** Limited human research has ventured into nattokinase's effects on atherosclerosis or lipid profiles. While some animal studies and early human observations suggest potential benefits, such as reducing carotid artery intima-media thickness in patients with atherosclerosis, more robust and larger-scale clinical trials are needed to confirm these effects. Examine.com provides a summary of the current evidence, noting that while promising, these areas require further investigation. In summary, there is a consistent body of evidence supporting nattokinase's fibrinolytic activity and its potential to modestly lower blood pressure. Its broader applications in severe cardiovascular conditions require more extensive clinical validation. The evidence for other benefits, such as direct anti-atherosclerotic effects, is still emerging.

Nattokinase is generally considered safe for most healthy individuals when consumed orally in appropriate amounts. However, like any biologically active substance, it can cause side effects, particularly due to its blood-thinning properties. Commonly reported side effects, though rare, are often related to its impact on blood coagulation processes: * **Increased Bleeding Risk:** The most significant concern is an increased risk of bleeding or bruising, especially in individuals prone to bleeding or those undergoing surgery. This can manifest as easier bruising, nosebleeds, or prolonged bleeding from cuts. * **Gastrointestinal Upset:** Some individuals may experience mild gastrointestinal symptoms such as nausea, diarrhea, or abdominal discomfort. These are typically transient. * **Allergic Reactions:** Although uncommon, allergic reactions are possible, particularly in individuals with a sensitivity to soybeans, from which nattokinase is derived. Symptoms could include rash, itching, or swelling. Less common or anecdotal reports include dizziness or headaches. Due to its mechanism of action, any side effect profile is closely tied to its impact on blood coagulation. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.

Given Nattokinase's potent effects on blood clotting, several warnings are crucial for safe use: * **Bleeding Disorders:** Individuals with diagnosed bleeding disorders such as hemophilia, or those with a history of intracranial hemorrhage, should avoid nattokinase due to the significantly increased risk of bleeding. * **Upcoming Surgery/Dental Procedures:** Nattokinase should be discontinued at least two weeks prior to any planned surgery or dental procedure to minimize the risk of excessive bleeding. Always inform your surgeon or dentist about all supplements you are taking. * **Trauma:** In cases of recent major trauma or injury, nattokinase could exacerbate bleeding and should not be used. * **Uncontrolled High Blood Pressure:** While nattokinase may modestly lower blood pressure, individuals with severely uncontrolled high blood pressure should exercise caution and use it only under medical supervision. Rapid or significant changes in blood pressure can be dangerous. * **Pregnancy and Breastfeeding:** There is insufficient reliable information about the safety of nattokinase during pregnancy and breastfeeding. Therefore, it is generally advised to avoid its use during these periods. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.

Nattokinase is contraindicated in several situations where its blood-thinning effects could pose a significant health risk: * **Anticoagulant or Antiplatelet Medications:** Concomitant use with prescription anticoagulant medications (e.g., warfarin, heparin, rivaroxaban, dabigatran) or antiplatelet drugs (e.g., aspirin, clopidogrel) is strictly contraindicated. The combination can dangerously increase the risk of bleeding or hemorrhage. * **Bleeding Disorders:** Any individual with a pre-existing bleeding disorder, such as hemophilia, von Willebrand disease, or other coagulopathies, should not use nattokinase. * **Recent Stroke or Surgery:** Nattokinase is contraindicated in individuals who have recently experienced an ischemic stroke, hemorrhagic stroke, or have recently undergone major surgery, due to the heightened risk of bleeding complications. * **Active Bleeding:** Anyone experiencing active bleeding (e.g., gastrointestinal bleeding, acute trauma with active hemorrhage) should not take nattokinase. * **Severe Liver or Kidney Disease:** In severe liver or kidney impairment, the metabolism and excretion of nattokinase and its interaction with the coagulation system might be unpredictable, leading to increased risk. * **Known Allergy to Soy:** Since nattokinase is derived from fermented soybeans, individuals with a known allergy to soy products should avoid it. Always consult a healthcare professional before considering nattokinase, especially if you have any pre-existing medical conditions or are taking other medications.

Due to its potent fibrinolytic and potential anticoagulant properties, Nattokinase should absolutely *not* be mixed with certain medications and supplements to avoid dangerous interactions: * **Anticoagulants (Blood Thinners):** This includes prescription medications like warfarin (Coumadin), heparin, dabigatran (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis). Combining nattokinase with these drugs can lead to a significantly increased risk of severe bleeding or hemorrhage. * **Antiplatelet Drugs:** Medications such as aspirin, clopidogrel (Plavix), prasugrel (Effient), and ticagrelor (Brilinta) inhibit platelet aggregation. Concurrent use with nattokinase can heighten the risk of bleeding. * **Other Fibrinolytic Agents:** Any other medications or supplements known to dissolve blood clots should be avoided in combination with nattokinase to prevent excessive fibrinolysis and bleeding. * **NSAIDs (Nonsteroidal Anti-Inflammatory Drugs):** Over-the-counter and prescription NSAIDs like ibuprofen (Advil, Motrin), naproxen (Aleve), and celecoxib (Celebrex) can have mild antiplatelet effects and may increase bleeding risk when combined with nattokinase, particularly in higher doses or with prolonged use. * **Other Supplements with Blood-Thinning Effects:** Caution is warranted when combining nattokinase with other natural supplements known or suspected to have blood-thinning properties, such as garlic, ginger, ginkgo biloba, high-dose vitamin E, fish oil, and turmeric. While interactions may vary, the cumulative effect could increase bleeding risk. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.

There is no universally prescribed timing for Nattokinase intake, and specific recommendations can depend on the desired effect and individual tolerance. However, based on common practice and mechanistic considerations: * **With or Without Food:** Nattokinase can generally be taken with or without food. Some individuals prefer to take it with a meal to minimize any potential gastrointestinal discomfort, although it is often formulated in enteric-coated capsules to protect the enzyme from stomach acid. * **Empty Stomach for Maximal Absorption:** Some proponents suggest taking nattokinase on an empty stomach (e.g., 30 minutes before a meal or 2 hours after) to potentially maximize its systemic absorption and enzymatic activity, as food components might theoretically interfere with its proteolytic action. However, scientific evidence definitively proving this to be a superior approach for efficacy is limited. * **Before Bed:** Taking nattokinase before bedtime is a common recommendation, particularly for those interested in its systemic effects on blood circulation, as processes related to blood viscosity and clot formation can be active during rest. * **Consistent Daily Intake:** Regardless of the exact timing, consistency is generally considered more important for sustained effects. Taking it at roughly the same time each day can help maintain stable levels in the body. Individual needs vary, and a licensed clinician can provide tailored advice on timing and dosage. Always follow the specific instructions provided on the supplement label or by a healthcare professional.